4//SEC Filing
KKR Phorm Investors L.P. 4
Accession 0001140361-20-005779
CIK 0001715768other
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 5:07 PM ET
Size
17.2 KB
Accession
0001140361-20-005779
Insider Transaction Report
Form 4
Transphorm, Inc.NONE
KKR Phorm Investors L.P.
10% Owner
Transactions
- Purchase
Common Stock
2020-02-12$4.00/sh+1,250,000$5,000,000→ 21,175,980 total(indirect: See footnotes)
Footnotes (2)
- [F1]The securities reported herein are held by KKR Phorm Investors L.P. KKR Phorm Investors GP LLC is the general partner of KKR Phorm Investors L.P., KKR Group Partnership L.P. is the sole member of KKR Phorm Investors GP LLC, KKR Group Holdings Corp. is the general partner of KKR Group Partnership L.P., KKR & Co. Inc. is the sole shareholder of KKR Group Holdings Corp., KKR Management LLP is the Class B common stockholder of KKR & Co. Inc., and Messrs. Henry R. Kravis and George R. Roberts are the founding partners of KKR Management LLP.
- [F2]Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein.
Documents
Issuer
Transphorm, Inc.
CIK 0001715768
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001806548
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 5:07 PM ET
- Size
- 17.2 KB